Tempest Therapeutics (TPST) Stock Price
$6.9 0.7%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
3 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Tempest Therapeutics, AI stock picks, stock alerts and much more.
TPST AI Stock Analysis
AI stock analysis for TPST is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Tempest Therapeutics (TPST) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Tempest Therapeutics (TPST) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Tempest Therapeutics (TPST), currently trading at $6.9, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About TPST
-
Tempest Therapeutics Inc.
-
Symbol
TPST
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
25.4M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.81 1.8% |
6 |
 |
Inovio Pharmaceuticals INO |
$1.95 2.6% |
3 |
 |
Moderna MRNA |
$25.4 0.6% |
3 |
 |
Anavex Life Sciences AVXL |
$9.03 1.2% |
7 |
 |
BridgeBio Pharma BBIO |
$40 0.2% |
7 |
News
TPST Alternative Data
Web Traffic
Tempest Therapeutics receives an estimated 5482 monthly visitors to tempesttx.com.
-
Web Traffic
5482
-
Change from Previous Month
15%
-
3 Month Change
15.8%
-
YoY Change
15.8%
Twitter Followers
Tempest Therapeutics has 383 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
383
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
1.6%
-
YoY Change
1.6%
LinkedIn Followers
4,245 are following Tempest Therapeutics on LinkedIn, up by 0.7% over the last month.
-
LinkedIn Followers
4245
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
7.7%
Job Postings
Tempest Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Employees
According to LinkedIn, Tempest Therapeutics has 26 employees, down by -13.3% over the last month.
-
LinkedIn Employees
26
-
Daily Change
0%
-
1 Month Change
13.3%
-
3 Month Change
7.1%
-
YoY Change
7.1%
News Mentions
Tempest Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Tempest Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
TPST Financials
TPST Key Metrics
-
Total Revenue
$486K
-
Net Income
-$13.8M
-
Earnings per Share
-$0.5
-
Free cash flow
$22.9M
-
EBITDA
-$13.5M
-
EBITDA Ratio
-27.8128
-
Total Assets
$41.5M
TPST 2-year Revenue & Income
TPST 2-year Free Cash Flow
TPST Technicals
TPST SMA
TPST RSI
FAQ
What's the current price of Tempest Therapeutics (TPST) Stock?
The price of an Tempest Therapeutics (TPST) share is $6.9.
What's the market cap of Tempest Therapeutics?
The current market cap of Tempest Therapeutics is 25.4M.
Should I buy or sell TPST?
Tempest Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Tempest Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Tempest Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Tempest Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Tempest Therapeutics (TPST) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Tempest Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Tempest Therapeutics (TPST) that investors often compare it to?
Tempest Therapeutics (TPST) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Tempest Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Tempest Therapeutics' stock price to be around $6.37 in 2026. Starting from the current price of $6.9, this represents a 7.6% change in price, indicating a bearish outlook for the stock.
How to buy Tempest Therapeutics (TPST) Stock?
Tempest Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Tempest Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.